









市場
/
株式
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

54.900USD

-0.600-1.08%

終値 08/29, 16:00（ET）15分遅れの株価

3.73B時価総額

14.68直近12ヶ月PER



Lantheus Holdings Inc

54.900

-0.600-1.08%

概要企業名金融分析

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. It has pre-clinical assets, specifically the TROP2 and DUNP19.

企業情報

企業コードLNTH

会社名Lantheus Holdings Inc

上場日Jun 25, 2015

最高経営責任者「CEO」Mr. Brian A. Markison

従業員数808

証券種類Ordinary Share

決算期末Jun 25

本社所在地331 Treble Cove Road

都市NORTH BILLERICA

証券取引所NASDAQ Global Market Consolidated

国United States of America

郵便番号01862

電話番号19786718001

ウェブサイトhttps://www.lantheus.com/

企業コードLNTH

上場日Jun 25, 2015

最高経営責任者「CEO」Mr. Brian A. Markison

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+34.47%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+450.62%

Mr. Samuel R. (Sam) Leno

Independent Director

Ms. Jamie Spaeth

Chief People Officer

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

収益内訳

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

株主

更新時刻: Fri, Aug 15

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

11.03%

Janus Henderson Investors

10.21%

The Vanguard Group, Inc.

10.03%

Fidelity Management & Research Company LLC

6.08%

Farallon Capital Management, L.L.C.

4.88%

他の

57.78%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

11.03%

Janus Henderson Investors

10.21%

The Vanguard Group, Inc.

10.03%

Fidelity Management & Research Company LLC

6.08%

Farallon Capital Management, L.L.C.

4.88%

他の

57.78%

種類

株主統計

比率

Investment Advisor

57.48%

Investment Advisor/Hedge Fund

45.03%

Hedge Fund

6.89%

Research Firm

3.61%

Individual Investor

2.32%

Pension Fund

1.94%

Bank and Trust

1.50%

Sovereign Wealth Fund

0.74%

Venture Capital

0.11%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

1039

82.20M

120.88%

-4.84M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

2023Q2

790

72.85M

106.61%

-3.94M

2023Q1

733

71.94M

105.47%

-6.73M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

7.79M

11.27%

+17.69K

+0.23%

Mar 31, 2025

Janus Henderson Investors

6.26M

9.05%

-252.58K

-3.88%

May 30, 2025

The Vanguard Group, Inc.

6.99M

10.1%

-242.63K

-3.36%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.17M

3.14%

+148.84K

+7.36%

Mar 31, 2025

Farallon Capital Management, L.L.C.

6.02M

8.71%

+707.00K

+13.30%

Mar 31, 2025

State Street Global Advisors (US)

2.64M

3.81%

-4.26K

-0.16%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.78M

2.57%

+94.57K

+5.62%

Mar 31, 2025

Wellington Management Company, LLP

909.10K

1.31%

+685.29K

+306.19%

Mar 31, 2025

Westfield Capital Management Company, L.P.

1.59M

2.3%

+34.05K

+2.19%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.41M

2.04%

-96.91K

-6.42%

Mar 31, 2025

詳細を見る